National Institutes of Health
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing March 5, 2027.
Mar 5, 2027
(217d left)